Please Wait...

Operating with a strong sense of business integrity and corporate responsibility is critical to maintain trust and credibility. Bioclinica's management team is comprised of clinical trial experts with years of clinical trial, bioimaging, data management, business management, technology and pharmaceutical industry experience. Together, our clinical trial experts are dedicated to deliver better results for all of our clients' clinical trials, globally.

Executive Leadership Team


John Hubbard, Ph.D., FCP

President, Chief Executive Officer & Member of the Board of Directors

Bioclinica


David S. Herron

President

Medical Imaging & eHealth


Maria Kraus

Executive Vice President

Corporate Development & Strategy


David Peters

Chief Financial Officer

Bioclinica


Todd Kisner

Vice President

Quality & Regulatory Affairs


Christopher P. Orlando

Executive Vice President

General Counsel & Chief Compliance Officer


Clinton J. Wolfe

Executive Vice President

Global Human Resources


David Kiger

Chief Commercial Officer

Medical Imaging & eHealth Solutions

Global Clinical Research

eHealth Solutions

Medical Imaging & Biomarker Services

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Great advice from our Dir. Cardiovascular Imaging on how to achieve top quality imaging acquisitions & assessments… https://t.co/P57970FrOf
bioclinica (14 hours ago)
RT @CenterWatch: #CWWeekly: The increasing trend of adopting digital health and #mhealth apps for patient care. Read more, https://t.co/wo9…
bioclinica (15 hours ago)
RT @CenterWatch: Examining the difference between #patient engagement & patient recruitment. Read more in #CWPulse by @AshleyTointon, https…
bioclinica (15 hours ago)
RT @CenterWatch: How can #socialmedia play a role in health disparities and #clinicaltrial patient recruitment? Read more in #CWPulse by @A…
bioclinica (15 hours ago)
RT @RAPSorg: What New @FDAcdrhIndustry Guidance is Coming in FY 2018: Alternative 510(k) Pathway and More | #Regulatory Recon https://t.co/…
bioclinica (15 hours ago)
RT @RAPSorg: .@US_FDA Finalizes Guidance on Promotional Drug Labeling and Ads | #Regulatory Focus https://t.co/2rmtTWajlf #FDA #pharma
bioclinica (15 hours ago)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen
Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices